New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 14, 2013
07:30 EDTVSIVitamin Shoppe pullback a buying opportunity, says Piper Jaffray
Piper Jaffray recommends using the recent pullback in shares of Vitamin Shoppe as a buying opportunity. Piper says Vitamin Shoppe's pricing has been consistently above competitors online and that it believes the company's sales and margins are likely going well in Q4. The firm keeps an Overweight rating on the stock with a $68 price target.
News For VSI From The Last 14 Days
Check below for free stories on VSI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
15:09 EDTVSIVitamin Shoppe holders urge exploration of sale to GNC or pe firm, Reuters says
Subscribe for More Information
14:53 EDTVSIVitamin Shoppe jumps 4% after report of stakeholder urging sale exploration
Subscribe for More Information
14:53 EDTVSIVitamin Shoppe being called on to sell itself by shareholders, Reuters says
Subscribe for More Information
September 12, 2014
10:35 EDTVSIVitamin Shoppe may consider selling itself, analyst says
Vitamin retailer Vitamin Shoppe (VSI) could be considering selling itself after its 52 year old CEO announced that he would retire, Sterne Agee wrote in a note to investors today. WHAT'S NEW: After Vitamin Shoppe announced on September 10 that its CEO Tony Truesdale would retire effective June 2015, Sterne Agee analyst Charles Grom wrote that the news was surprising, in light of Truesdale's age and several initiatives recently carried out by the company. Given Truesdale's departure and the lack of available high-caliber retail management talent, along with Vitamin Shoppe's recent move into manufacturing via its acquisition of nutritional product maker Nutri-Force, Vitamin Shoppe's board may be considering selling the company, the analyst believes. Vitamin Shoppe could be weighing selling itself to competitor GNC (GNC) or a private equity firm, Grom wrote. He kept a $53 price target and Buy rating on Vitamin Shoppe. WHAT'S NOTABLE: In a note to investors on August 11, Credit Suisse predicted that GNC and Vitamin Shoppe could combine. The merger would create $135M of synergies and grow the combined entity's earnings before interest taxes depreciation and amortization by nearly 20%, the analyst predicted. Additionally, the companies have a great deal of store overlap, and the new CEO of GNC is a former president of Vitamin Shoppe, increasing the chances that a merger would be successful, Credit Suisse stated. PRICE ACTION: In mid-morning trading, Vitamin Shoppe lost 1% to $43, while GNC advanced 1% to $39.50.
09:20 EDTVSIVitamin Shoppe may be weighing sale of company, says Sterne Agee
Subscribe for More Information
September 11, 2014
10:49 EDTVSIHigh option volume stocks
Subscribe for More Information
September 10, 2014
16:19 EDTVSIVitamin Shoppe says CEO Tony Truesdale plans to retire next year
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use